Effect of erythropoietin on parameters of sympathetic nervous activity in patients undergoing chronic haemodialysis.

British Journal of Clinical Pharmacology

Volumn 30, Issue 1 S, 1990, Pages 135S-138S

  Fritschka, E ^a   Neumayer, HH ^a   Seddighi, S ^a   Thiede, HM ^a   Distler, A ^a   Philipp, T ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BRIMONIDINE; CATECHOLAMINE; ERYTHROPOIETIN; HEMOGLOBIN; NORADRENALIN; RADIOISOTOPE; YOHIMBINE;

ADRENERGIC SYSTEM; ADULT; BLOOD PRESSURE; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

BLOOD PLATELETS; BLOOD PRESSURE; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; NOREPINEPHRINE; RANDOM ALLOCATION; RECEPTORS, ADRENERGIC, ALPHA; RENAL DIALYSIS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0025028826     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1990.tb05485.x     Document Type: Article

References (7)

1. Recombinant human erythropoietin: implications for nephrology
2. Correction of the anemia of end stage renal disease with recombinant human erythropoietin
3. Effect of nifedipine and verapamil on alpha receptor activation in patients with essential hypertension
4. 2‐adrenoceptor density in normotensive and hypertensive man
5. Sympathetic nervous system and blood pressure control in essential hypertension
6. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy
7. 3H‐UK‐14,304: regulation by Gpp(NH)p and cations